The UCSF-GIVI CFAR Virology Core Laboratory provides laboratory services, consultation and training formultidisciplinary, translational research in order to advance collaborators' research programs in theprevention, treatment and understanding of HIV/AIDS. The laboratory typically supports 50 studies annually,ranging from small investigational pilot studies to large, multi-center clinical trials. Collectively, this work hassignificantly broadened our understanding of HIV disease pathogenesis, transmission and treatment.
The specific aims of the laboratory are to provide:1. Service through development and implementation of molecular diagnostic assays and analysis toolsunder strict adherence to rigorous operational procedures and quality assurance programs.2. Research through scientific leadership and laboratory resources to advance our understanding of HIV-1 transmission and correlates of protection that may lead to novel strategies for prevention. Viral replication in the context of latency and partial ARV drug suppression. The causes and consequences of ARV drug resistance. Host factors that modulate HIV replication and evolution. HIV replication and evolution in tissue compartments with a focus on transmission, antiretroviraldrug resistance and disease progression.3. Education and outreach through Mentoring and training of junior investigators and research scientists focused on translationalresearch in local, national and international settings. Consultation with research collaborators, junior scientists and community members to assist inthe interpretation and comprehension of virologic research findings.By collaborating with an increasingly strong network of multidisciplinary basic and clinical scientists, theVirology Core Laboratory is strategically and operationally poised to leverage CFAR funding to effectivelysupport translational research, and advance our understanding of HIV transmission and diseasepathogenesis, identify new and optimize the use of existing antiviral agents, and to guide vaccine design.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027763-16
Application #
7278983
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Project Start
2007-07-01
Project End
2012-08-31
Budget Start
2007-07-01
Budget End
2008-08-31
Support Year
16
Fiscal Year
2007
Total Cost
$232,508
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Shehata, Hesham M; Khan, Shahzada; Chen, Elise et al. (2018) Lack of Sprouty 1 and 2 enhances survival of effector CD8+ T cells and yields more protective memory cells. Proc Natl Acad Sci U S A 115:E8939-E8947
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Scherzer, Rebecca; Shah, Sanjiv J; Secemsky, Eric et al. (2018) Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection. Circ Heart Fail 11:e004312
Yoon, Christina; Semitala, Fred C; Asege, Lucy et al. (2018) Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV. Am J Respir Crit Care Med :
Tang, Eric C; Vittinghoff, Eric; Anderson, Peter L et al. (2018) Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project. J Acquir Immune Defic Syndr 77:193-198
Hosseinipour, Mina C; Kang, Minhee; Krown, Susan E et al. (2018) As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis 67:251-260
Tang, Weiming; Liu, Chuncheng; Cao, Bolin et al. (2018) Receiving HIV Serostatus Disclosure from Partners Before Sex: Results from an Online Survey of Chinese Men Who Have Sex with Men. AIDS Behav 22:3826-3835
Ayers, Leona W; Barbachano-Guerrero, Arturo; McAllister, Shane C et al. (2018) Mast Cell Activation and KSHV Infection in Kaposi Sarcoma. Clin Cancer Res 24:5085-5097
Tamraz, Bani; Huang, Yong; French, Audrey L et al. (2018) A Genome-Wide Association Study Identifies a Candidate Gene Associated With Atazanavir Exposure Measured in Hair. Clin Pharmacol Ther 104:949-956
Clutton, Genevieve Tyndale; Jones, R Brad (2018) Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure. Front Immunol 9:1452

Showing the most recent 10 out of 1541 publications